• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

MR spectroscopy moves from the brain to bones

Article

Characterizing musculoskeletal tumors with MR spectroscopy could eliminate the need for standard imaging and histological staging. Researchers at Johns Hopkins University have found preliminary success using MRS at 3T to diagnose bone tumors.

Characterizing musculoskeletal tumors with MR spectroscopy could eliminate the need for standard imaging and histological staging. Researchers at Johns Hopkins University have found preliminary success using MRS at 3T to diagnose bone tumors.

Dr. Laura M. Fayad, an assistant professor of radiology, and colleagues examined six bone tumors. They correctly detected a choline peak in two malignant cases and no choline peak in four benign cases, Fayad told Diagnostic Imaging.

The group had previously been successful in using MRS at 1.5T to investigate resected tumors. Fayad reported that study at the 2004 RSNA meeting.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.